Location History:
- Upsala, SE (1993 - 1998)
- Uppsala, SE (1993 - 2000)
Company Filing History:
Years Active: 1993-2000
Title: Innovations and Contributions of Christer Wernstedt
Introduction
Christer Wernstedt is a notable inventor based in Upsala, Sweden. He has made significant contributions to the field of cancer research, holding a total of 8 patents. His work primarily focuses on the mechanisms of protein interactions and their implications in cancer biology.
Latest Patents
Wernstedt's latest patents include groundbreaking inventions related to Smad2 phosphorylation and its interaction with Smad4. This invention describes specific amino acid residues of the Smad2 protein that are crucial for its phosphorylation and activity. It also covers Smad2 polypeptide fragments and biologically functional variants, including dominant-negative variants and related antibodies. Additionally, the patents provide methods and products for utilizing these nucleic acids and polypeptides in therapeutic applications.
Another significant patent involves peptides derived from platelet-derived endothelial cell growth factor (PD-ECGF). This 45 kDa endothelial cell mitogen, purified from human platelets, has shown angiogenic activity in vitro, stimulating the formation of new blood vessels. Wernstedt's invention offers a homogeneous PD-ECGF in greater yields than previously available, along with its primary structure, antibodies, and therapeutic preparations.
Career Highlights
Wernstedt is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to advance research in cancer biology. His innovative work has contributed to a deeper understanding of protein interactions and their roles in cancer progression.
Collaborations
Wernstedt has collaborated with esteemed colleagues such as Ulf G Hellman and Kohei Miyazono, further enhancing the impact of his research through shared expertise and knowledge.
Conclusion
Christer Wernstedt's contributions to cancer research through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in therapeutic strategies against cancer.